文献速递肥胖与代谢综合征性腺与生殖内分泌甲状腺疾病

BDV综合征:一种新出现的伴有重度肥胖和神经发育迟缓的综合征,类似Prader-Willi综合征

BDV Syndrome: An Emerging Syndrome With Profound Obesity and Neurodevelopmental Delay Resembling Prader-Willi Syndrome.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

本研究报道了来自3个近亲家庭的4例携带CPE双等位基因功能丧失变异患者,均表现为重度肥胖、神经发育迟缓和内分泌异常。通过外显子测序和计算建模,研究者将这一可识别的临床表型命名为BDV综合征,其与Prader-Willi综合征相似。双等位基因截短CPE变异与BDV综合征相关,错义变异也可能具有临床意义。

要点

  • CPE双等位基因截短变异导致BDV综合征,表现为儿童期起病肥胖、神经发育迟缓和低促性腺激素性性腺功能减退。
  • BDV综合征临床表型与Prader-Willi综合征相似,需注意鉴别诊断。
  • 错义变异可能也具有临床相关性,计算分析提示CPE结构域高度保守且不耐受错义改变。

核心结论

  • CPE双等位基因截短变异与BDV综合征相关,这是一种可识别的单基因隐性综合征,表现为儿童期起病肥胖、神经发育迟缓、低促性腺激素性性腺功能减退和甲状腺功能减退。
  • BDV综合征与Prader-Willi综合征相似,错义变异也可能具有临床相关性。

研究设计与样本

  • 本研究描述了来自3个无血缘关系的近亲家庭的4例患者,其中2例为叙利亚兄妹,1例为埃及裔,1例为巴基斯坦裔,均携带新的纯合CPE功能丧失变异。
  • 在排除Prader-Willi综合征后,对叙利亚兄妹进行了外显子测序;另外2例个体的变异来自大规模外显子研究的研究性变异和ClinVar数据库。
  • 对所有可能的错义改变进行了计算建模,以评估CPE对错义变异的耐受性。

主要发现

  • 所有患者均表现为重度肥胖、神经发育迟缓和其它内分泌异常。
  • 来自2个家庭的3例患者共享相同的CPE纯合截短变异c.361C > T,p.(Arg121*),第4例携带c.994del,p.(Ser333Alafs*22)变异。
  • 与既往病例的临床特征比较并根据人类表型本体术语标准化后,提示存在可识别的临床表型,被命名为Blakemore-Durmaz-Vasileiou(BDV)综合征。
  • 计算分析表明CPE结构域高度保守且不耐受错义改变。

临床怎么用

  • 对于表现为重度肥胖、神经发育迟缓和低促性腺激素性性腺功能减退的儿童,在排除Prader-Willi综合征后,应考虑CPE相关BDV综合征并进行基因检测。
  • BDV综合征患者可能伴有甲状腺功能减退,临床管理中需评估甲状腺功能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: CPE encodes carboxypeptidase E, an enzyme that converts proneuropeptides and propeptide hormones to bioactive forms. It is widely expressed in the endocrine and central nervous system. To date, 4 individuals from 2 families with core clinical features including morbid obesity, neurodevelopmental delay, and hypogonadotropic hypogonadism, harboring biallelic loss-of-function (LoF) CPE variants, have been reported. OBJECTIVE: We describe 4 affected individuals from 3 unrelated consanguineous families, 2 siblings of Syrian, 1 of Egyptian, and 1 of Pakistani descent, all harboring novel homozygous CPE LoF variants. METHODS: After excluding Prader-Willi syndrome (PWS), exome sequencing was performed in both Syrian siblings. The variants identified in the other 2 individuals were reported as research variants in a large-scale exome study and in the ClinVar database. Computational modeling of all possible missense alterations allowed assessing CPE tolerance to missense variants. RESULTS: All affected individuals were severely obese with neurodevelopmental delay and other endocrine anomalies. Three individuals from 2 families shared the same CPE homozygous truncating variant c.361C > T, p.(Arg121*), while the fourth carried the c.994del, p.(Ser333Alafs*22) variant. Comparison of clinical features with previously described cases and standardization according to the Human Phenotype Ontology terms indicated a recognizable clinical phenotype, which we termed Blakemore-Durmaz-Vasileiou (BDV) syndrome. Computational analysis indicated high conservation of CPE domains and intolerance to missense changes. CONCLUSION: Biallelic truncating CPE variants are associated with BDV syndrome, a clinically recognizable monogenic recessive syndrome with childhood-onset obesity, neurodevelopmental delay, hypogonadotropic hypogonadism, and hypothyroidism. BDV syndrome resembles PWS. Our findings suggest missense variants may also be clinically relevant.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Bosch E, Hebebrand M, Popp B, et al. BDV Syndrome: An Emerging Syndrome With Profound Obesity and Neurodevelopmental Delay Resembling Prader-Willi Syndrome. J Clin Endocrinol Metab. 2021. PMID: 34383079. doi:10.1210/clinem/dgab592

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。